INTRODUCTION
Primary motoneuron diseases that selectively involve subsets of motoneurons (upper and/or lower) are widely distributed in animal species. Most of these diseases result in motoneuron degeneration by apoptotic and non-apoptotic processes. They include human spinal muscular atrophies (SMA) and amyotrophic lateral sclerosis (ALS) or the murine mutations wobbler (wr), muscle deficient (mdf), progressive motor neuronopathy (pmn), and motoneuron degeneration (mnd). These spontaneous diseases present distinct phenotypes and genotypes. The mechanisms of selective vulnerability, cytoskeletal abnormalities, and cell death involving the neuronal populations at risk are not yet well understood.
Over the past several years, MND has been attributed to diverse causes including genetic abnormalities (i. e., mutations in copper/zinc superoxide dismutase 1 (SOD1) and androgen receptor genes) (La Spada et al., 1991; Rosen et al., 1993) ; glutamate receptor mediated excitotoxicity which involves calcium influx (Lipton & Rosenberg, 1994) ; inmunological mechanisms (Appel et al., 1993) ; perturbation in neuronal cytoskeleton (Brady, 1993; Pernas Alonso et al., 1997; Julien, 1999) .
Direct evidence that cytoskeletal disorganization plays a key role in motoneuron diseases has emerged from the work of two laboratories that have shown that two-to fourfold hyperexpression in transgenic mice of either mouse NFL (Xu et al., 1993) or human NFH (Cotè et al., 1993) results in motoneuron pathology that resembles symptoms present in SMA and ALS. The relationship between NF expression and motoneuron degeneration in other transgenic animals appears controversial. Indeed, a twofold increase of NFM does not lead to neuronal loss, although it results in altered ratios of the three neurofilament subunits and abnormal filamentous aggregates in cell bodies and axons (Wong et al., 1995) . On the other hand, copper/zinc superoxide dismutase 1 (SOD1) mutation effects on motoneuron degeneration and ax-
